- Home
- NRK vs CRMD Comparison
NRK vs CRMD Comparison
Compare NRK & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRK
- CRMD
- Stock Information
- Founded
- NRK 2002
- CRMD 2006
- Country
- NRK United States
- CRMD United States
- Employees
- NRK N/A
- CRMD N/A
- Industry
- NRK Trusts Except Educational Religious and Charitable
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NRK Finance
- CRMD Health Care
- Exchange
- NRK Nasdaq
- CRMD Nasdaq
- Market Cap
- NRK 824.4M
- CRMD 865.2M
- IPO Year
- NRK N/A
- CRMD 2010
- Fundamental
- Price
- NRK $10.17
- CRMD $11.16
- Analyst Decision
- NRK
- CRMD Strong Buy
- Analyst Count
- NRK 0
- CRMD 8
- Target Price
- NRK N/A
- CRMD $17.57
- AVG Volume (30 Days)
- NRK 187.3K
- CRMD 2.7M
- Earning Date
- NRK 01-01-0001
- CRMD 10-29-2025
- Dividend Yield
- NRK 4.10%
- CRMD N/A
- EPS Growth
- NRK N/A
- CRMD N/A
- EPS
- NRK N/A
- CRMD 0.79
- Revenue
- NRK N/A
- CRMD $121,484,498.00
- Revenue This Year
- NRK N/A
- CRMD $480.51
- Revenue Next Year
- NRK N/A
- CRMD $59.81
- P/E Ratio
- NRK N/A
- CRMD $14.02
- Revenue Growth
- NRK N/A
- CRMD 14970.29
- 52 Week Low
- NRK $8.95
- CRMD $5.60
- 52 Week High
- NRK $11.09
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- NRK 67.20
- CRMD 41.78
- Support Level
- NRK $10.06
- CRMD $10.95
- Resistance Level
- NRK $10.29
- CRMD $11.71
- Average True Range (ATR)
- NRK 0.08
- CRMD 0.53
- MACD
- NRK -0.00
- CRMD 0.01
- Stochastic Oscillator
- NRK 54.84
- CRMD 17.91
About NRK Nuveen New York AMT-Free Quality Municipal Income Fund
Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.